Aisling Capital Iv, Lp Elevation Oncology, Inc. (ELEV) insider trading activity

ELEV Quotes by TradingView

Aisling Capital Iv, LP is of Elevation Oncology, Inc.. Currently has a direct ownership of 2.83 Million shares of ELEV, which is worth approximately $1.64 Million. The most recent transaction as insider was on Jun 29, 2021, when has been sold 187,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $3,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.83M
0% 3M change
0% 12M change
Total Value Held $1.64 Million

Aisling Capital IV, LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
BUY
Open market or private purchase
$3,000,000 $16.0 p/Share
187,500 Added 6.2%
2,834,910 Common Stock
Jun 29 2021
BUY
Conversion of derivative security
-
2,351,592 Added 47.04%
2,647,410 Common Stock
ACI

Aisling Capital Iv, LP

New York, NY

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELEV